Kelly D. McCall, Ph.D.
Affiliations: | 2003 | Ohio University, Athens, OH, United States |
Area:
Molecular BiologyGoogle:
"Kelly McCall"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Xiao-zhuo Chen | grad student | 2003 | Ohio University | |
| (Function determination of the zebrafish bmp-4 gene using an optimized ribozyme -mediated gene knockdown system.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ghazanfari D, Courreges MC, Belinski L, et al. (2022) Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19. Biochemical and Biophysical Research Communications. 605: 171-176 |
| Noori MS, Courreges MC, Bergmeier SC, et al. (2020) Modulation of LPS-induced inflammatory cytokine production by a novel glycogen synthase kinase-3 inhibitor. European Journal of Pharmacology. 173340 |
| Walter DL, Benner SE, Oaks RJ, et al. (2020) Coxsackievirus B4 Exposure Results in Variable Pattern Recognition Response in the Kidneys of Female Non-obese Diabetic Mice Before Establishment of Diabetes. Viral Immunology |
| McCall KD, Muccioli M, Benencia F. (2020) Toll-Like Receptors Signaling in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1223: 81-97 |
| Muccioli M, Nandigam H, Loftus T, et al. (2018) Modulation of double-stranded RNA pattern recognition receptor signaling in ovarian cancer cells promotes inflammatory queues. Oncotarget. 9: 36666-36683 |
| Patton A, Church T, Wilson C, et al. (2018) Phenylmethimazole abrogates diet-induced inflammation, glucose intolerance and NAFLD. The Journal of Endocrinology |
| Schwartz AL, Dickerson E, Dagia N, et al. (2017) TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration. Oncotarget. 8: 113295-113302 |
| Noori MS, O'Brien JD, Champa ZJ, et al. (2017) Phenylmethimazole and a thiazole derivative of phenylmethimazole inhibit IL-6 expression by triple negative breast cancer cells. European Journal of Pharmacology |
| Ilieva LB, Claybaugh T, Thuma JR, et al. (2017) Early antioxidant supplementation in the prevention of diabetic nephropathy: alterations in NOS expression precede renal functional decline Moj Anatomy & Physiology. 4 |
| Schwartz AL, Dickerson E, Dagia N, et al. (2016) TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration. Oncotarget |